CN117597148A - 非水膨润性的皮膜形成型外用剂基剂 - Google Patents
非水膨润性的皮膜形成型外用剂基剂 Download PDFInfo
- Publication number
- CN117597148A CN117597148A CN202280046831.5A CN202280046831A CN117597148A CN 117597148 A CN117597148 A CN 117597148A CN 202280046831 A CN202280046831 A CN 202280046831A CN 117597148 A CN117597148 A CN 117597148A
- Authority
- CN
- China
- Prior art keywords
- film
- external preparation
- water
- acid
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 82
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 71
- 229920000642 polymer Polymers 0.000 claims abstract description 67
- 239000000839 emulsion Substances 0.000 claims abstract description 61
- 230000008961 swelling Effects 0.000 claims abstract description 27
- 150000002148 esters Chemical class 0.000 claims abstract description 25
- 239000002245 particle Substances 0.000 claims abstract description 21
- 239000002904 solvent Substances 0.000 claims abstract description 17
- 239000003960 organic solvent Substances 0.000 claims abstract description 15
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 13
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 13
- 239000004014 plasticizer Substances 0.000 claims abstract description 10
- 229920000058 polyacrylate Polymers 0.000 claims abstract description 10
- 230000009477 glass transition Effects 0.000 claims abstract description 7
- -1 fatty acid ester Chemical class 0.000 claims description 58
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 30
- 239000002202 Polyethylene glycol Substances 0.000 claims description 30
- 229920001223 polyethylene glycol Polymers 0.000 claims description 30
- 239000003814 drug Substances 0.000 claims description 28
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 26
- 239000000194 fatty acid Substances 0.000 claims description 26
- 229930195729 fatty acid Natural products 0.000 claims description 26
- 239000000178 monomer Substances 0.000 claims description 26
- 239000003921 oil Substances 0.000 claims description 21
- 235000019198 oils Nutrition 0.000 claims description 21
- 229920001296 polysiloxane Polymers 0.000 claims description 15
- 229920001577 copolymer Polymers 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 12
- 150000004665 fatty acids Chemical class 0.000 claims description 11
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 10
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 claims description 8
- 229920002678 cellulose Polymers 0.000 claims description 8
- 235000010980 cellulose Nutrition 0.000 claims description 8
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 8
- 229930195733 hydrocarbon Natural products 0.000 claims description 8
- 150000002430 hydrocarbons Chemical class 0.000 claims description 8
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 8
- 239000008158 vegetable oil Substances 0.000 claims description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 6
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 6
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 6
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 6
- 239000005642 Oleic acid Substances 0.000 claims description 6
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000010775 animal oil Substances 0.000 claims description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 6
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 6
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 6
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 6
- 229940057995 liquid paraffin Drugs 0.000 claims description 6
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 6
- 239000011505 plaster Substances 0.000 claims description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 6
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 claims description 5
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 5
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 5
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 5
- 229940119170 jojoba wax Drugs 0.000 claims description 5
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 5
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 claims description 5
- 229940073665 octyldodecyl myristate Drugs 0.000 claims description 5
- 229940032094 squalane Drugs 0.000 claims description 5
- 239000005639 Lauric acid Substances 0.000 claims description 4
- 235000021355 Stearic acid Nutrition 0.000 claims description 4
- 238000005470 impregnation Methods 0.000 claims description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 4
- 239000008117 stearic acid Substances 0.000 claims description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims description 3
- 235000018330 Macadamia integrifolia Nutrition 0.000 claims description 3
- 235000003800 Macadamia tetraphylla Nutrition 0.000 claims description 3
- 240000000912 Macadamia tetraphylla Species 0.000 claims description 3
- 230000000202 analgesic effect Effects 0.000 claims description 3
- 239000003908 antipruritic agent Substances 0.000 claims description 3
- 239000004359 castor oil Substances 0.000 claims description 3
- 235000019438 castor oil Nutrition 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 239000000645 desinfectant Substances 0.000 claims description 3
- 125000005456 glyceride group Chemical group 0.000 claims description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 3
- 239000003906 humectant Substances 0.000 claims description 3
- 239000010466 nut oil Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims description 3
- 201000004647 tinea pedis Diseases 0.000 claims description 3
- 229940099259 vaseline Drugs 0.000 claims description 3
- 230000001139 anti-pruritic effect Effects 0.000 claims description 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 206010040880 Skin irritation Diseases 0.000 abstract description 6
- 230000036556 skin irritation Effects 0.000 abstract description 6
- 231100000475 skin irritation Toxicity 0.000 abstract description 6
- 239000012736 aqueous medium Substances 0.000 abstract description 4
- 238000001035 drying Methods 0.000 abstract description 4
- 238000007654 immersion Methods 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 239000000654 additive Substances 0.000 description 12
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 11
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000003995 emulsifying agent Substances 0.000 description 9
- 230000002209 hydrophobic effect Effects 0.000 description 9
- 239000004480 active ingredient Substances 0.000 description 8
- 125000005250 alkyl acrylate group Chemical group 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000000049 pigment Substances 0.000 description 8
- 229920000800 acrylic rubber Polymers 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 230000000996 additive effect Effects 0.000 description 6
- 230000007794 irritation Effects 0.000 description 6
- 235000002639 sodium chloride Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 238000002296 dynamic light scattering Methods 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000003125 aqueous solvent Substances 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 4
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 238000005452 bending Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 2
- 239000004373 Pullulan Substances 0.000 description 2
- 229920001218 Pullulan Polymers 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229920006243 acrylic copolymer Polymers 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229940023476 agar Drugs 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- 229960001950 benzethonium chloride Drugs 0.000 description 2
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 229960004365 benzoic acid Drugs 0.000 description 2
- 229960002903 benzyl benzoate Drugs 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 229960004926 chlorobutanol Drugs 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 238000004455 differential thermal analysis Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 229960003511 macrogol Drugs 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 2
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 235000019423 pullulan Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- DTGKSKDOIYIVQL-NQMVMOMDSA-N (+)-Borneol Natural products C1C[C@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-NQMVMOMDSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 1
- WFXHUBZUIFLWCV-UHFFFAOYSA-N (2,2-dimethyl-3-octanoyloxypropyl) octanoate Chemical compound CCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCC WFXHUBZUIFLWCV-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- NVZWEEGUWXZOKI-UHFFFAOYSA-N 1-ethenyl-2-methylbenzene Chemical compound CC1=CC=CC=C1C=C NVZWEEGUWXZOKI-UHFFFAOYSA-N 0.000 description 1
- OORMAUIUZSKZFA-UHFFFAOYSA-N 1-hexadecoxyhexadecane;octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC OORMAUIUZSKZFA-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- VFZRCLLDPCNXPS-UHFFFAOYSA-N 2,2,4,4,6,6,8,8,10,10-decamethyl-1,3,5,7,9,11-hexaoxa-2,4,6,8,10,12-hexasilacyclododecane Chemical compound C[Si]1(C)O[SiH2]O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 VFZRCLLDPCNXPS-UHFFFAOYSA-N 0.000 description 1
- RNNHLXAEVKCLDG-UHFFFAOYSA-N 2,2,4,4,6,6,8,8-octamethyl-1,3,5,7,9,2,4,6,8,10-pentaoxapentasilecane Chemical compound C[Si]1(C)O[SiH2]O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 RNNHLXAEVKCLDG-UHFFFAOYSA-N 0.000 description 1
- STMDPCBYJCIZOD-UHFFFAOYSA-N 2-(2,4-dinitroanilino)-4-methylpentanoic acid Chemical compound CC(C)CC(C(O)=O)NC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O STMDPCBYJCIZOD-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- WQNHWIYLCRZRLR-UHFFFAOYSA-N 2-(3-hydroxy-2,5-dioxooxolan-3-yl)acetic acid Chemical compound OC(=O)CC1(O)CC(=O)OC1=O WQNHWIYLCRZRLR-UHFFFAOYSA-N 0.000 description 1
- YSUQLAYJZDEMOT-UHFFFAOYSA-N 2-(butoxymethyl)oxirane Chemical compound CCCCOCC1CO1 YSUQLAYJZDEMOT-UHFFFAOYSA-N 0.000 description 1
- AVBJHQDHVYGQLS-UHFFFAOYSA-N 2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- SBYMUDUGTIKLCR-UHFFFAOYSA-N 2-chloroethenylbenzene Chemical compound ClC=CC1=CC=CC=C1 SBYMUDUGTIKLCR-UHFFFAOYSA-N 0.000 description 1
- ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 2-dodecanoyloxyethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCC ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- DXIJHCSGLOHNES-UHFFFAOYSA-N 3,3-dimethylbut-1-enylbenzene Chemical compound CC(C)(C)C=CC1=CC=CC=C1 DXIJHCSGLOHNES-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 235000003884 Aspalathus contaminatus Nutrition 0.000 description 1
- 235000012984 Aspalathus linearis Nutrition 0.000 description 1
- 240000006914 Aspalathus linearis Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000213948 Astragalus sinicus Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- MOZDKDIOPSPTBH-UHFFFAOYSA-N Benzyl parahydroxybenzoate Chemical compound C1=CC(O)=CC=C1C(=O)OCC1=CC=CC=C1 MOZDKDIOPSPTBH-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- OXJGJKIURHREKH-UHFFFAOYSA-O CC(=C)C(=O)OCCP(=O)=C(O)C[N+](C)(C)C Chemical compound CC(=C)C(=O)OCCP(=O)=C(O)C[N+](C)(C)C OXJGJKIURHREKH-UHFFFAOYSA-O 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 208000003643 Callosities Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 244000141009 Hypericum perforatum Species 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 description 1
- CMHMMKSPYOOVGI-UHFFFAOYSA-N Isopropylparaben Chemical compound CC(C)OC(=O)C1=CC=C(O)C=C1 CMHMMKSPYOOVGI-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- YQLLDALKLIDLCT-UHFFFAOYSA-N O.C(C)(=O)ON(CCN(OC(C)=O)OC(C)=O)OC(C)=O.[Na] Chemical compound O.C(C)(=O)ON(CCN(OC(C)=O)OC(C)=O)OC(C)=O.[Na] YQLLDALKLIDLCT-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 235000002912 Salvia officinalis Nutrition 0.000 description 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 description 1
- 244000173853 Sanguisorba officinalis Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 240000000785 Tagetes erecta Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- OWRMXHRUFYLLQP-UHFFFAOYSA-N [3-[2,3-bis(16-methylheptadecanoyloxy)propoxy]-2-hydroxypropyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C OWRMXHRUFYLLQP-UHFFFAOYSA-N 0.000 description 1
- YDSMOSYAJQRHKJ-UHFFFAOYSA-I [Al+3].[Zn++].CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O Chemical compound [Al+3].[Zn++].CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O YDSMOSYAJQRHKJ-UHFFFAOYSA-I 0.000 description 1
- SYZKBMPNHSQNHG-UHFFFAOYSA-N [Na].CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.NCCN Chemical compound [Na].CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.NCCN SYZKBMPNHSQNHG-UHFFFAOYSA-N 0.000 description 1
- ZIALXKMBHWELGF-UHFFFAOYSA-N [Na].[Cu] Chemical compound [Na].[Cu] ZIALXKMBHWELGF-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- PKJKFLHTQJUUII-UHFFFAOYSA-N acetic acid;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;ethane-1,2-diamine Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.NCCN.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O PKJKFLHTQJUUII-UHFFFAOYSA-N 0.000 description 1
- FRTNIYVUDIHXPG-UHFFFAOYSA-N acetic acid;ethane-1,2-diamine Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.NCCN FRTNIYVUDIHXPG-UHFFFAOYSA-N 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 229940103272 aluminum potassium sulfate Drugs 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000010477 apricot oil Substances 0.000 description 1
- 235000016520 artichoke thistle Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000010338 boric acid Nutrition 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000007765 cera alba Substances 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 229960001305 cysteine hydrochloride Drugs 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 238000012674 dispersion polymerization Methods 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 229920001821 foam rubber Polymers 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N isomenthone Natural products CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- FSQQTNAZHBEJLS-UPHRSURJSA-N maleamic acid Chemical compound NC(=O)\C=C/C(O)=O FSQQTNAZHBEJLS-UPHRSURJSA-N 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- QEWXHPFKSMVJKX-UHFFFAOYSA-N octadecanoic acid;1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC QEWXHPFKSMVJKX-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- XCRBXWCUXJNEFX-UHFFFAOYSA-N peroxybenzoic acid Chemical compound OOC(=O)C1=CC=CC=C1 XCRBXWCUXJNEFX-UHFFFAOYSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- QTECDUFMBMSHKR-UHFFFAOYSA-N prop-2-enyl prop-2-enoate Chemical compound C=CCOC(=O)C=C QTECDUFMBMSHKR-UHFFFAOYSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 235000015639 rosmarinus officinalis Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229940001482 sodium sulfite Drugs 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- DGSDBJMBHCQYGN-UHFFFAOYSA-M sodium;2-ethylhexyl sulfate Chemical compound [Na+].CCCCC(CC)COS([O-])(=O)=O DGSDBJMBHCQYGN-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- 239000002383 tung oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明的技术问题为提供用于皮肤刺激性低、有速干性,且耐水性等优良的非水膨润性的皮膜形成型外用剂的基剂。本发明例如可举出包含如下成分A~成分C的非水膨润性的皮膜形成型外用剂基剂:A)由(甲基)丙烯酸类聚合物等的聚合物粒子分散于水介质中而成的水性聚合物乳剂所构成的皮膜形成剂,其中所述聚合物的玻璃化转变温度及所述乳剂的最低成膜温度均为30℃以下,且将所形成的皮膜浸渍于水中24小时使其膨润时的由下述式所算出的膨润率小于30%,膨润率(%)=(W1‑W2)/W1×100(式中,W1为浸渍前重量(g)、W2为浸渍后重量(g));B)酯类非离子性表面活性剂等增塑剂;及C)载体溶剂,其为水、或水及基剂总量中小于20质量%的有机溶剂。
Description
技术领域
本发明属于外用剂的技术领域。本发明涉及用于在使用前为液态或凝胶状,但若涂布于皮肤时,载体成分的溶剂挥发,于皮肤上形成皮膜的皮膜形成型外用剂(例如液态绊创膏)的基剂。本发明的皮膜形成型外用剂基剂,具有即使将形成于皮肤上的皮膜暴露于水也不易膨润的特性,故为非水膨润性。
技术背景
作为施用于皮肤的外用剂之一,已知有于使用前为液态或凝胶状,但若涂布于皮肤时,载体成分的溶剂蒸发,于皮肤上形成皮膜的皮膜形成型外用剂(例如液体绊创膏)。该皮膜形成型外用剂,剥离时的物理刺激少,可依损伤部位的大小、形状形成皮膜,故为便利的。此外,也可以容器直接涂布。
作为皮膜形成型外用剂的皮膜形成剂,自以往起,例如已知有羟丙基纤维素、纤维素类树脂、聚乙烯醇及聚乙烯吡咯烷酮等水溶性高分子(专利文献1~3)、(甲基)丙烯酸类聚合物(专利文献4)、焦木素(专利文献5)。
水性聚合物乳剂为于水等水性溶剂中分散有聚合物粒子的乳剂,若该水性溶剂挥发时,通过聚合物粒子彼此成为一起而熔接及变形,从而形成皮膜。该水性聚合物乳剂,例如于化妆品领域中使用,专利文献6中,公开了涉及使用了水性聚合物乳剂的人工爪被覆用组合物的发明。
现有技术文献
专利文献
[专利文献1]日本特开昭59-139325号公报
[专利文献2]日本特开平03-275619号公报
[专利文献3]日本特开平06-157327号公报
[专利文献4]日本特开平09-2943号公报
[专利文献5]日本特开平05-58914号公报
[专利文献6]日本特开2015-199702号公报
发明内容
所要解决的技术问题
以往的皮膜形成型外用剂中为了谋求迅速形成皮膜,而使用醇、有机溶剂作为载体成分,但存在该醇、有机溶剂所致的皮肤刺激、或皮膜形成而成的膜无耐水性的问题。就(甲基)丙烯酸类聚合物、焦木素而言,形成具有耐水性的皮膜,但配合醇、有机溶剂所致的皮肤刺激仍强。对皮肤的刺激性,可通过以凝胶或乳膏、软膏等的形态施用,而某种程度地避免,但如此一来存在新诱发如涂布部的黏附或对衣服的附着的问题的风险。此外,为了洗去凝胶等,涂布后必需清洗手指。此外,至今为止的皮膜形成型外用剂中,尚未发现充分满足如皮肤刺激性低、有速干性、密合于皮肤而吸收性、耐水性优良,进而有柔软性、伸缩性及强度这样的条件的。
另一方面,就以水为载体溶剂的水性外用剂而言,虽可避免对皮肤的刺激性,但由于为水性故干燥慢,皮膜的形成需要时间。此外,当用于医药时,药效成分中为多的疏水性药物由于难溶于水故难以配合于水性的外用剂中,在水性外用剂中配合药物时,有限于亲水性药物的风险。
本发明的主要技术问题为提供用于皮肤刺激性低、有速干性,此外,满足如耐水性、柔软性、伸缩性及强度这样的条件的新颖的非水膨润性的皮膜形成型外用剂的基剂。
解决技术问题的手段
为了解决所述技术问题,本发明者深入探讨的结果,发现通过在由一定的水性聚合物乳剂所构成的皮膜形成剂中添加数种添加物,可解决所述技术问题,而完成本发明。
本发明例如可举出下述方式。
[1]一种非水膨润性的皮膜形成型外用剂基剂,其包含如下成分A~成分C:
A)皮膜形成剂,其由选自(甲基)丙烯酸类聚合物及分子内包含(甲基)丙烯酸类单体的共聚物的聚合物粒子分散于水介质中而成的水性聚合物乳剂所构成,其中所述聚合物的玻璃化转变温度及所述乳剂的最低成膜温度均为30℃以下,且将所形成的皮膜浸渍于水中24小时使其膨润时的由下述式所算出的膨润率小于30%,
膨润率(%)=(W1-W2)/W1×100
(式中,W1表示浸渍前重量(g)、W2表示浸渍后重量(g));
B)增塑剂,其为选自酯类非离子性表面活性剂及纤维素类中的1种以上;及
C)载体溶剂,其为水、或水及基剂总量中小于20质量%的有机溶剂。
[2]根据所述[1]所述的皮膜形成型外用剂基剂,其进一步包含水不溶性的油分。
[3]根据所述[1]所述的皮膜形成型外用剂基剂,其中,所述聚合物为(甲基)丙烯酸烷基酯聚合物、或包含(甲基)丙烯酸烷基酯单体的共聚物。
[4]根据所述[1]所述的皮膜形成型外用剂基剂,其中,以动态光散射法测定时的所述聚合物粒子的平均粒径为10~300nm的范围内。
[5]根据所述[1]所述的皮膜形成型外用剂基剂,其中,所述水性乳剂中的聚合物固体成分量为20~70质量%的范围内。
[6]根据所述[1]所述的皮膜形成型外用剂基剂,其中,所述酯类非离子性表面活性剂为聚乙二醇单脂肪酸酯,所述纤维素类为羟丙基纤维素。
[7]根据所述[1]所述的非水膨润性的皮膜形成型外用剂基剂,其中,所述水不溶性的油分为选自酯类、烃类、脂肪酸、动植物油及聚硅氧烷中的1种以上。
[8]根据所述[7]所述的皮膜形成型外用剂基剂,其中,酯类为肉豆蔻酸异丙酯、肉豆蔻酸辛基十二烷酯、生育酚乙酸酯、三(辛酸/癸酸)甘油酯、或癸二酸二乙酯;烃类为液体石蜡、角鲨烷、或凡士林;脂肪酸为月桂酸、肉豆蔻酸、硬脂酸、异硬脂酸、或油酸;动植物油为蓖麻油、荷荷巴油、或澳洲坚果油;或聚硅氧烷为聚二甲基硅氧烷。
[9]一种非医药用外用剂,其包含根据所述[1]~[8]中任一项所述的皮膜形成型外用剂基剂。
[10]一种医药用外用剂,其包含根据所述[1]~[8]中任一项所述的皮膜形成型外用剂基剂与药效成分。
[11]根据所述[10]所述的医药用外用剂,其为液体绊创膏。
[12]根据所述[10]所述的医药用外用剂,其中,所述药效成分为杀菌消毒剂、足癣药、止痒剂、保湿剂、或镇痛消炎剂。
[13]根据所述[9]所述的非医药用外用剂,其中,外用剂被封入于推针型容器、迷你滚珠容器或迷你滚珠容器、喷雾容器、或附刷毛容器。
[14]根据所述[10]所述的医药用外用剂,其中,外用剂被封入于推针型容器、滚珠容器或迷你滚珠容器、喷雾容器、或附刷毛容器。
发明效果
本发明的非水膨润性的皮膜形成型外用剂基剂(以下称“本发明基剂”),由于载体溶剂基本上为水,故不仅即使对皮肤涂布刺激性也少,且可无迟滞地干燥,而于皮肤上形成皮膜。此外,例如柔软性、伸缩性、耐水性优良。而一旦成膜时,即使暴露于水也不易膨润,因此可比较长时间停留于皮肤上。此外,使用本发明基剂作为医药用外用剂的基剂时,可广泛地配合从亲水性药物到疏水性药物。
具体实施方式
1本发明基剂
本发明基剂,其特征为包含如下成分A~成分C。
A)皮膜形成剂,其由选自(甲基)丙烯酸类聚合物及分子内包含(甲基)丙烯酸类单体的共聚物的聚合物粒子分散于水介质中而成的水性聚合物乳剂所构成,其中所述聚合物的玻璃化转变温度及所述乳剂的最低成膜温度均为30℃以下,且将所形成的皮膜浸渍于水中24小时使其膨润时的由下述式所算出的膨润率小于30%。
膨润率(%)=(W1-W2)/W1×100
(式中,W1及W2与所述同义)。
B)增塑剂,其为选自酯类非离子性表面活性剂及纤维素类中的1种以上。
C)载体溶剂,其为水、或水及基剂总量中小于20质量%的有机溶剂。
1.1关于成分A
本发明基剂包含成分A。成分A为皮膜形成剂,其由选自(甲基)丙烯酸类聚合物及分子内包含(甲基)丙烯酸类单体的共聚物的聚合物粒子分散于水介质中而成的水性聚合物乳剂所构成,该皮膜形成剂中,所述聚合物的玻璃化转变温度(Tg)、及所述乳剂的最低成膜温度(MFT:Minimum Film-forming Temperature)均为30℃以下,且将所形成的皮膜浸渍于水中24小时使其膨润时的由下述式所算出的膨润率小于30%。该皮膜形成剂的成分A为水溶液。
膨润率(%)=(W1-W2)/W1×100
(式中,W1及W2与所述同义)。
水性聚合物乳剂,如前所述为于水等水性溶剂中分散有聚合物粒子者,若该水性溶剂挥发时,聚合物粒子彼此成为一起而熔接及变形,从而形成皮膜。因而,基本上通过成分A,于皮肤上形成由聚合物等所构成的皮膜。此外,分散有聚合物粒子的水基本上作为本发明基剂的载体溶剂。因此,本发明基剂包含水。
成分A中的水性聚合物乳剂或其中所包含的聚合物,Tg及MFT均为30℃以下,优选Tg及MFT均为28℃至26℃~-15℃的范围内。如由后述试验结果明显可知,由Tg及MFT的任一者高于30℃的聚合物所构成的水性乳剂,难以于皮肤上形成皮膜。
玻璃化转变温度(Tg)为本领域技术人员众所周知的物性,可通过常规方法求得。具体而言,例如可举出一边使聚合物试样的温度慢慢上升或下降一边测定力学物性的变化或吸热/放热的方法(例如差示扫描热量测定(DSC)、差热分析(DTA))、机械式分光术(动态黏弹性测定)法。此外,可通过所谓的Fox公式计算Tg。
最低成膜温度(MFT)为以均质且透明的皮膜的形态凝集的最低温度,可通过常规方法,以最低成膜温度测定装置来求得。
此外,就本发明的水性聚合物乳剂所形成的皮膜而言,由所述式所算出的膨润率小于30%,若该膨润率为30%以上,则存在将形成于皮肤上的皮膜暴露于水时有白浊而耐水性不良的风险。
成分A中的水性聚合物乳剂的聚合物由(甲基)丙烯酸类聚合物及分子内包含(甲基)丙烯酸类单体的共聚物中选择。此处,“(甲基)丙烯酸,”意指一并称呼丙烯酸与甲基丙烯酸的用语。
本发明中,优选为以(甲基)丙烯酸烷基酯为主要构成单体的聚合物或共聚物((甲基)丙烯酸烷基酯聚合物)。其中,例如也可以以(甲基)丙烯酸、或疏水性单体、亲水性单体的1种以上作为构成单体而含于分子内。
作为所述聚合性单体的(甲基)丙烯酸烷基酯,例如可举出(甲基)丙烯酸甲酯、(甲基)丙烯酸乙酯、(甲基)丙烯酸异丙酯、(甲基)丙烯酸正丁酯、(甲基)丙烯酸异丁酯、(甲基)丙烯酸正戊酯、(甲基)丙烯酸异戊酯、(甲基)丙烯酸正己酯、(甲基)丙烯酸2-乙基己酯、(甲基)丙烯酸辛酯、(甲基)丙烯酸癸酯、(甲基)丙烯酸十二烷酯、(甲基)丙烯酸十八烷酯、(甲基)丙烯酸环己酯、(甲基)丙烯酸苯酯、(甲基)丙烯酸苄酯、(甲基)丙烯酸异戊酯。其中优选为(甲基)丙烯酸甲酯、(甲基)丙烯酸乙酯、(甲基)丙烯酸正丁酯、(甲基)丙烯酸异丁酯、(甲基)丙烯酸正丁酯、(甲基)丙烯酸异丁酯、(甲基)丙烯酸异戊酯。此等可为1种、也可为任意的2种以上。
所述疏水性单体例如可举出苯乙烯、2-甲基苯乙烯、叔丁基苯乙烯、氯苯乙烯等苯乙烯类单体;丙烯酸烯丙酯等烯丙基类单体;氯乙烯等氯乙烯类单体;丁基缩水甘油醚、(甲基)丙烯酸缩水甘油酯、(甲基)丙烯酸二缩水甘油酯、烯丙基缩水甘油醚等环氧类单体;二甲基硅氧烷等聚硅氧烷类单体;胺基甲酸酯等胺基甲酸酯类单体。
所述亲水性单体例如可举出(甲基)丙烯酸2-羟基乙酯、(甲基)丙烯酸羟基丙酯等在侧链具有羟基的(甲基)丙烯酸烷基酯;丙烯酰胺、马来酸酰胺、N-羟甲基(甲基)丙烯酰胺等酰胺类单体;马来酸酐等马来酸类单体、乙酸乙烯酯等乙烯基类单体。
成分A中的水性聚合物乳剂的制造方法不特别限制,例如可通过将丙烯酸类单体、乳化剂等原料于水中均匀分散,将该单体以乳化剂进行胶束化,并对其添加聚合引发剂(例如过氧化氢、过氧乙酸、叔丁基氢过氧化物、过氧苯甲酸)加热并乳液聚合,来制造该水性聚合物乳剂。此外,也可通过使用了反应性乳化剂的无皂聚合法、或不含乳化剂的水介质不均匀聚合法等手法来制造。
所述乳化剂例如可举出聚氧乙烯壬基苯基醚等聚氧乙烯烷基苯基醚、聚氧乙烯十二烷基醚等聚氧化烯烷基醚等非离子类乳化剂;聚氧化烯烷基醚硫酸酯铵、聚氧乙烯月桂基醚硫酸酯钠、2-乙基己基硫酸酯钠、二辛基磺琥珀酸钠等的阴离子类乳化剂。
成分A中的水性聚合物乳剂中的聚合物粒子的平均粒径不特别限制,以动态光散射法(DLS)进行测定时,以重均粒径计,例如以10~300nm的范围内为适当,优选为30~200nm的范围内、更优选为40~200nm的范围内。该平均粒径例如可使用纳米粒径测定装置Nanotrac WaveII(MICROTRAC公司制)、Z etasizer PRO(Spectris公司制)来测定。
成分A中的水性聚合物乳剂中的聚合物固体成分量不特别限制,以20~70质量%的范围内为适当,优选为35~55质量%的范围内。
成分A中的水性聚合物乳剂的1%水溶液的黏度,于室温下为1~10000m Pa·s,优选为3~5000mPa·s、更优选为5~3000mPa。
成分A中的水性聚合物乳剂有市售,本发明中可使用市售品。其具体例子,可举出丙烯酸烷基酯乳剂(COVACRTL MS11 WP(Sensient Technologies公司制)、YODOSOL GH810F(Nouryon Japan公司制)、Vinysol 1086WP(大同化成工业公司制)等)、丙烯酸烷基酯/苯乙烯共聚乳剂(TODOSOL GH41H(No uryon Japan公司制)、Vinysol 1012JC(大同化成工业公司制)等)。
本发明基剂中的成分A的含量,可依期望适当设定,不特别限制。
1.2关于成分B
成分B为增塑剂,其为选自酯类非离子性表面活性剂及纤维素类中的1种以上,本发明基剂包含该成分B。成分B对形成于皮肤上的皮膜(成膜)赋予柔软性与伸缩性,维持成膜的耐水性。
此处“酯类非离子性表面活性剂”是指溶解于中性水时,具有不离子化的亲水基团的表面活性剂,其具备甘油、二醇、乙二醇、山梨醇、蔗糖等多元醇与脂肪酸进行酯键合而得的结构。
成分B中的酯类非离子性表面活性剂,例如可举出聚氧化烯脂肪酸酯、高级醇脂肪酸酯、乙二醇脂肪酸酯、丙二醇脂肪酸酯、丁二醇脂肪酸酯、山梨醇酐脂肪酸酯、甘油脂肪酸酯、蔗糖脂肪酸酯。聚氧化烯脂肪酸酯,例如可举出聚乙二醇(单、二、三)脂肪酸酯。该脂肪酸,例如可举出硬脂酸、油酸、异硬脂酸、月桂酸、鲸蜡基醚硬脂酸、硬脂基醚硬脂酸。作为成分B中的酯类非离子性表面活性剂的具体例子,可举出聚乙二醇单硬脂酸酯(例如MYS-10V、MYS-25V、MYS-45MV、MYS-55MV(Nikko Chemicals公司制))、聚乙二醇单油酸酯(例如MYO-10V(Nikko Chemicals公司制))、聚乙二醇单异硬脂酸酯、聚乙二醇单月桂酸酯(例如MYL-10V(Nikko Chemicals公司制))、聚乙二醇二月桂酸酯、聚乙二醇二硬脂酸酯、聚乙二醇二油酸酯。其中,优选聚乙二醇单脂肪酸酯,其中更优选聚乙二醇单油酸酯、聚乙二醇单月桂酸酯。
作为成分B中的纤维素类,例如可举出羟丙基纤维素、羟丙甲纤维素(hypromellose)、疏水化羟丙基甲基纤维素。其中优选羟丙基纤维素。
成分B可为所述任1种,也可组合使用任意2种以上。
本发明基剂中的成分B的含量根据期望而适当设定,不特别限制,以0.01~50质量%的范围内为适当,优选为0.1~30质量%的范围内、更优选为0.5~20质量%的范围内。少于0.01质量%时,有得不到充分的柔软性、伸缩性的风险,多于50质量%时,有对形成于皮肤上的皮膜的柔软性、伸缩性或耐水性造成不良影响的风险。
1.3关于成分C
本发明基剂,包含水或水及本发明基剂总量中小于20质量%的有机溶剂,作为载体溶剂。此处“载体溶剂,”是指至将使用本发明基剂的制剂施用于皮肤为止,用以将皮膜形成剂的成分A、增塑剂的成分B等保持于基剂中的介质,其于皮肤施用后,最终会蒸发而消失。该载体溶剂以下称为“成分C。”
成分C基本上仅有水,本发明基剂中优选不包含机溶剂(0质量%)。成分C包含有机溶剂时,在本发明基剂总量中为小于20质量%,优选为小于15质量%、更优选为小于10质量%、进一步优选为小于5质量%或小于1质量%,应尽可能少。由于成分C基本上为水或包含水与仅少许的有机溶剂,故本发明基剂为低刺激性的。此外,耐水性也良好。
由于成分C最终会蒸发而消失,故本发明基剂中所包含的有机溶剂,通常为挥发性有机溶剂或低沸点有机溶剂,具体而言,例如可举出低级(碳数1~4左右)一元醇(例如甲醇、乙醇、丙醇、异丙醇、异丁醇)、丙酮、乙酸乙酯、甲醚、乙醚。一般而言为作为低级一元醇的乙醇。
成分C,如上所述,基本上为水,故包含乙醇等低级一元醇的有机溶剂,在本发明基剂中也可不包含,就刺激性的观点,优选为不包含。
1.4关于成分D
本发明基剂,可包含水不溶性的油分。该油分以下也称为“成分D。”成分D可协助疏水性药物溶解于本发明基剂,可使于本发明基剂中配合该药物为容易的。因此,成分D也可称为用于药物(药效成分)的增溶剂、溶解促进剂等。因而,本发明基剂除了可用于非医药用外用剂的制备以外,通过于本发明基剂中包含成分D,可更扩展对医药用外用剂的用途。
此处“水不溶性的油分”是指对于20℃的中性水的溶解度为100μg/mL以下的油性的化合物。作为成分D中的水不溶性的油分,只要符合所述目的则不特别限制,可适当选择,例如可举出酯类、烃类、脂肪酸、动植物油、聚硅氧烷。
酯类具体而言,例如可举出异辛酸鲸蜡酯、肉豆蔻酸异丙酯、棕榈酸异丙酯、肉豆蔻酸辛基十二烷酯、三辛酸甘油酯、二异硬脂酸聚甘油酯、三异硬脂酸二甘油酯、三-二十二酸甘油酯、三(辛酸/癸酸)甘油酯、苹果酸二异硬脂酯、二辛酸新戊二醇、癸二酸二乙酯、胆固醇脂肪酸酯、N-月桂酰基-L-谷氨酸二(胆固醇酯/二十二烷酯/辛基十二烷酯)、生育酚乙酸酯。
烃类具体而言,例如可举出液体石蜡、轻质液体石蜡、角鲨烷、凡士林。
脂肪酸具体而言,例如可举出二十二酸、月桂酸、肉豆蔻酸、硬脂酸、异硬脂酸、油酸。
动植物油具体而言,例如可举出鳄梨油、亚麻仁油、杏仁油、橄榄油、可可油、牛油、桐油、小麦胚芽油、芝麻油、米胚芽油、米糠油、红花籽油、大豆油、月见草油、山茶油、玉米油、菜籽油、马油、杏子油、棕榈油、棕榈仁油、蓖麻油、葵花油、猪油、葡萄籽油、荷荷巴油、澳洲坚果油、貂油、绵籽油、木蜡、蜂蜡、白蜂蜡、椰子油、硬化椰子油、花生油、羊毛脂、蛋黄油、玫瑰果油。
聚硅氧烷具体而言,例如可举出二甲基聚硅氧烷(聚二甲基硅氧烷)、高聚合甲基聚硅氧烷烷、甲基苯基聚硅氧烷烷、甲基氢聚硅氧烷烷、八甲基环四硅氧烷、八甲基环五硅氧烷、十甲基环六硅氧烷、硬脂氧基聚硅氧烷等高级烷氧基改性聚硅氧烷、烷基改性聚硅氧烷、高级脂肪酸酯改性聚硅氧烷。
所述水不溶性的油分可为所述任1种,也可组合使用任意2种以上。
本发明基剂中的成分D的含量根据期望而适当设定,不特别限制,以0.01~50质量%的范围内为适当,优选为0.5~25质量%的范围内、更优选为1~10质量%的范围内。少于0.01质量%时,有疏水性药物在基剂中的溶解不充分的情况,多于50质量%时,有对形成于皮肤上的皮膜的柔软性、伸缩性或耐水性造成不良影响的风险。
1.5其他
本发明基剂基本上不含乙醇等低级醇。因此,可称为非醇性水性基剂。
本发明基剂中,在不损害本发明的效果的范围,可依期望配合其他添加剂。该添加剂例如可举出稳定(化)剂、增溶剂、抗氧化剂、湿润剂、清凉化剂、着色剂、香味剂(香料)、乳化剂、黏着剂、黏着增强剂、黏稠(化)剂、pH调整剂、防腐剂、溶剂、收敛剂、螯合剂、增黏剂、刺激减低剂。
所述稳定(化)剂例如可举出抗坏血酸、乙二胺四乙酸钠水合物、氯化钠、氯化镁。
所述增溶剂例如可举出三乙酸甘油酯、D-甘露醇、D-山梨醇、苯甲酸苄酯、三氨基甲烷、胆固醇、三乙醇胺、碳酸钠、柠檬酸钠。
所述抗氧化剂例如可举出丁基羟基苯甲醚、亚硫酸钠、抗坏血酸及其盐、亚硫酸氢钠、亚硫酸钠、焦亚硫酸钠、苯并三唑、盐酸半胱氨酸、柠檬酸。
湿润剂例如可举出1,3-丁二醇、甲基纤维素、月桂基硫酸钠。
清凉化剂例如可举出薄荷醇(l-薄荷醇、dl-薄荷醇等)、樟脑(d-樟脑、dl-樟脑等)、氯丁醇、香叶醇、桉叶素、茴香脑、柠檬烯、龙脑等萜类、包含萜类的精油(薄荷油)。
所述着色剂例如可举出焦油色素(褐色201号、蓝色201号、黄色4号、黄色403号等)、焦糖、铜叶绿素钠、亚甲蓝、栀子色素、万寿菊色素、胡萝卜素色素、花青素色素、果汁色素、蔬菜色素、三氧化二铁等合成或天然来源的色素。
所述香味剂(香料)例如可举出丁香油、向日花香醛、d-龙脑。
所述乳化剂例如可举出蔗糖脂肪酸酯、氢化大豆磷脂质。
所述黏着剂例如可举出羧基乙烯基聚合物、羧甲基纤维素钠。
所述黏着增强剂例如可举出黄原胶、聚乙二醇(Macrogol)6000。
所述黏稠(化)剂例如可举出硅酸镁铝、聚乙烯醇。
所述pH调整剂例如可举出柠檬酸、柠檬酸钠、柠檬酸酐、苹果酸、马来酸、琥珀酸、富马酸、酒石酸、酒石酸钠、乳酸、乳酸钙、乳酸钠、乙酸、乙酸钠、冰醋酸等有机酸或其盐;盐酸、硫酸、磷酸、硼酸、磷酸氢钠、磷酸二氢钾、磷酸二氢钠、碳酸钠、碳酸氢钠等无机酸或其盐;氢氧化钠、氢氧化钾、氢氧化钙、氢氧化镁、硼砂等氢氧化碱;单乙醇胺、三乙醇胺、二乙醇胺、二异丙醇胺、三异丙醇胺等胺类。
所述防腐剂例如可举出对羟基苯甲酸甲酯、对羟基苯甲酸乙酯、对羟基苯甲酸丙酯、对羟基苯甲酸异丙酯、对羟基苯甲酸丁酯、对羟基苯甲酸异丁酯、对羟基苯甲酸苄酯、苯甲酸、苯甲酸钠、苯甲酸、苯甲酸苄酯、去氢乙酸钠、苯扎氯铵(benzalkonium chloride)、氯化鲸蜡基吡啶鎓、苄索氯铵(benz ethonium chloride)、氨基乙基磺酸、苯氧基乙醇、氯丁醇、苄醇、苯乙醇、百里酚、山梨酸及其盐。
所述溶剂例如可举出浓甘油、丙二醇、苄醇。
所述收敛剂例如可举出明矾、硫酸锌、硫酸铝钾、碱性乳酸铝锌等金属盐;单宁酸、柠檬酸、乳酸、琥珀酸等有机酸;源自植物(例如海藻、百里香、红茶、乌龙茶、绿茶、小连翘、金缕梅、枇杷、牡丹皮、虎耳草、博士茶、紫云英、朝鲜蓟、洋甘菊、桉树、柠檬、迷迭香、地榆、鼠尾草等)的成分。
所述螯合剂例如可举出乙二胺四乙酸(依地酸)、乙二胺四乙酸盐(钠盐(乙二胺四乙酸钠:日本药典、EDTA-2Na等)、钾盐等)、植酸、葡萄糖酸、多磷酸、偏磷酸。
所述增黏剂例如可举出瓜尔胶、果胶、普鲁兰糖、明胶、刺槐豆胶、鹿角菜胶、琼脂、聚葡甘露糖、卡德兰胶、结冷胶、黄原胶、聚乙二醇、膨润土、海藻酸、海藻酸丙二醇、聚乙二醇(Macrogol)、软骨素硫酸钠、玻尿酸、玻尿酸钠。
所述刺激减低剂例如可举出明胶、阿拉伯胶、普鲁兰糖、α化淀粉、洋菜、西黄蓍胶、海藻酸钠、海藻酸丙二醇酯、甘草萃取物、2-甲基丙烯酰氧基乙基磷酸胆碱。
所述添加剂依期望可为任1种,也可组合使用任意2种以上。
本发明基剂通常具有pH2~9的液性,就对皮肤的刺激性及皮肤使用感的观点,优选为pH3~8、更优选为pH4~8、特别优选为pH5~8。需要说明的是,该pH可通过所述pH调整剂的使用而适当调整。
本发明基剂只要具备1~10000mPa·s的范围内的黏度即可,就手指取用性、涂布容易性等的观点,优选为3~5000mPa·s的范围内、更优选为5~3000mPa·s的范围内。
本发明基剂所形成的皮膜,优选由所述式算出的膨润率小于30%、更优选为20%以下、特别优选为10%以下。该膨润率为30%以上时,形成于皮肤上的皮膜暴露于水时有白浊而耐水性不良的风险。该膨胀率的下限,例如可举出完全不膨胀的0%。
本发明基剂的制造方法不特别限制,可通过适当选择并配合本发明基剂的制备所必要的各种成分,并使用适当的搅拌机以常规方法进行搅拌等,来制造本发明基剂。
2本发明基剂的用途等
本发明基剂,可作为用于作为非医药品的皮膜形成型外用剂、或配合有医药品相关药效成分的皮膜形成型外用剂的基剂使用。本发明中,可包含含有本发明基剂且不含药效成分的杂货、化妆品等非医药用外用剂、及包含本发明基剂与药效成分的医药用外用剂。
作为本发明的非医药用外用剂的其一方式,可举出液体手套等杂货、睫毛膏等化妆品。
作为本发明的医药用外用剂的其一方式,可举出液体绊创膏、鸡眼/老茧用剂。以下将本发明的非医药用外用剂与本发明的医药用外用剂一并称为“本发明外用剂。”
医药用的本发明外用剂中,可配合从亲水性药物到疏水性药物的广范围的药效成分。亲水性药物,可直接配合于本发明基剂中,疏水性药物可直接或溶解于水不溶性的油分来进行配合。该药物(药效成分)例如可举出杀菌消毒剂、足癣药、止痒剂、保湿剂、镇痛消炎剂、抗组胺剂、抗炎剂、局部麻醉剂、角质软化剂、组织修复剂、皮肤保护剂、维生素剂。
医药用的本发明外用剂的制造方法不特别限制,例如可通过将本发明基剂及所期望的药效成分,以及依需要的添加物以常规方法用搅拌机等实施搅拌混合等操作来制造。更详细而言,例如可通过包含下述工序的方法,来制造医药用的本发明外用剂。非医药用的本发明外用剂的情况时,除了下述工序1外,可同样地进行制造。
工序1:将药物(药效成分)溶解(药物相)。
工序2:于本发明的水性乳剂中配合各种添加物,以搅拌机搅拌而制备本发明基剂(基剂相)。
工序3:对基剂相添加药物相,以搅拌机搅拌(原料制剂(bulk drug))。
工序4:将原料制剂使用填充机填充于任意容器。
本发明外用剂,可封入于密封状的任意容器,例如发泡橡胶内栓涂布容器、(迷你)滚珠容器、喷雾(喷射)容器、滴下容器、乳液容器、铝管、推针型容器中。可由该容器直接涂布于皮肤。就抑制涂布部的干燥的观点等,优选为封入于推针型容器、滚珠容器、迷你滚珠容器、喷雾容器、附刷毛容器中。
该容器的材质例如可举出聚乙烯、聚丙烯、聚对苯二甲酸乙二酯等塑料全部。
医药用的本发明外用剂的施用方法,是依疾病、药效成分、患部、性别、年龄等而异,不特别限制,通常,可每1日1次~数次涂布适量于皮肤等的外皮上的包含患部的区域来使用。涂布后,本发明外用剂会迅速干燥,于经涂布本发明外用剂的皮肤上形成皮膜。该皮膜即使暴露于水也不易膨润,若不施加任何力,则可比较长期间停留于皮肤上。
实施例
以下示出实施例或试验例以更具体说明本发明。但是本发明不受以下实施例等的任何限定。
[试验例1]水性聚合物乳剂的探讨
针对市售的下述水性聚合物乳剂(WPE),评价膜的形成状态。
该膜是将WPE液0.5g置入5.0cm2的圆形的聚丙烯制容器,于室温干燥一晚而制备的(涂布量:0.1g/cm2、n=3)。其结果示于表1及表2。
需要说明的是,膨润率(%)由如下方法算出(以下的试验例也同)。
测定所得到的膜的重量(W1)后,将该膜置入加入有纯水的玻璃容器,于室温下浸渍24小时。浸渍后从玻璃容器取出该膜,测定擦拭表面的水分后的该膜重量(W2),由下述式算出膨润率(%)。
膨润率(%)=(W1-W2)/W1×100
(式中,W1及W2与所述同义)。
此外,聚合物粒子的重均粒径,是使用Nanotrac WaveII(MICROTRAC公司制),通过动态光散射法(DLS)测定的。
<探讨中使用的市售的水性聚合物乳剂(WPE)的例子>
1:丙烯酸烷基酯共聚物乳剂(DERMACRYL、Matsumoto Trading公司制)
2:丙烯酸烷基酯共聚物乳剂(COVACRYL E14 WP、Sensient Technolog ies Japan公司制)
3:丙烯酸烷基酯共聚物乳剂(COVACRYL MS11 WP、Sensient Technol ogiesJapan公司制)
4:丙烯酸烷基酯共聚物乳剂(YODOSOL GH800F、Matsumoto Trading公司制)
5:丙烯酸烷基酯共聚物乳剂(YODOSOL GH810F、Matsumoto Trading公司制)
6:丙烯酸烷基酯共聚物乳剂(Vinysol 1086WP、大同化成工业公司制)
7:丙烯酸烷基酯共聚物乳剂(Vinysol 1089HT、大同化成工业公司制)
8:丙烯酸烷基酯/苯乙烯共聚物乳剂(YODOSOL GH41H、Matsumoto Tr ading公司制)
9:丙烯酸烷基酯/苯乙烯共聚物乳剂(Vinysol 1012JC、大同化成工业公司制)
10:丙烯酸烷基酯/苯乙烯共聚物乳剂(Vinysol 1013JH、大同化成工业公司制)
11:丙烯酸烷基酯/苯乙烯共聚物乳剂(Vinysol 1019CT、大同化成工业公司制)
12:丙烯酸烷基酯/乙酸乙烯酯共聚物乳剂(Vinysol 2140L、大同化成工业公司制)
13:丙烯酸烷基酯/乙酸乙烯酯共聚物乳剂(Vinysol 2140LH、大同化成工业公司制)
[表1]
[表2]
如表1及表2所示,玻璃化转变温度(Tg)与最低成膜温度(MFT)均高于30℃的水性聚合物乳剂7与10中未形成膜。就水性聚合物乳剂12及13而言,浸渍于纯水时白浊,膨润率全部超过30%,耐水性不良。另一方面,就水性聚合物乳剂3、5、6、8、9而言,即使浸渍于纯水也维持透明至半透明,膨润率小于30%,耐水性良好。
[试验例2]添加物:增塑剂的探讨1
秤量一定的添加物10质量%后,于其中添加所述水性聚合物乳剂6,成为100质量%。将该液体以搅拌机(IKAT18basic(ULTRA-TURRAX公司制))搅拌1分钟。使用所得到的液体0.5g,与试验例1同样地进行膜制备,评价所得到的膜的气泡状态、透明性、柔软性、伸缩性、强度、及耐水性(色调与柔软性)(n=3)。此外,各算出所得到的膜的膨润率。
各试验中,气泡与透明性的评价是对所得到的膜以目视进行的。柔软性的评价是将所得到的膜以手指折弯来进行的,伸缩性的评价是所得到的膜以手指拉伸来进行的,强度的评价是将所得到的膜以手指多次折弯来进行的。耐水性的评价是将所得到的膜于加入有纯水的玻璃容器中室温下浸渍24小时,浸渍后从玻璃容器将膜取出,擦拭表面的水分后,颜色是以目视、柔软性是就折弯时的硬度的观点来进行的。各自通过评分方式进行评价(以下的试验也相同)。其结果示于表3及表4。
[表3]
[表4]
如表3及表4所示,仅以水性聚合物乳剂6形成皮膜时,该皮膜强度佳,浸渍于纯水时维持透明,膨润率为9.3%而耐水性优良,但稍欠缺柔软性,几乎无伸缩性。于水性聚合物乳剂6中添加多元醇、多糖类时,虽提高所得到的膜的柔软性及伸缩性,但将该膜浸渍于纯水时会白浊,耐水性恶化。此外,配合表面活性剂时,也有基剂凝集的情况,但添加作为酯类的非离子性表面活性剂的聚乙二醇单油酸酯时,所得到的膜的柔软性及伸缩性改善,将该膜浸渍于纯水时的膨润率为20%以下,维持半透明。就纤维素类而言,特别是羟丙基纤维素会改善所得到的膜的柔软性及伸缩性,将该膜浸渍于纯水时的膨润率为20%以下,维持半透明。
[试验例3]添加物:增塑剂的浓度的探讨
试验例2中,由于作为酯类非离子性表面活性剂的聚乙二醇单油酸酯的结果良好,故针对聚乙二醇单油酸酯的添加量进行探讨。试验使用水性聚合物乳剂6与9作为皮膜形成剂,与试验例2同样地进行膜制备,针对所制备的膜进行与试验例2相同的评价(n=3)。其结果示于表5与表6。
[表5]
[表6]
如表5及表6所示,皮膜形成剂的水性聚合物乳剂6及9,均随着聚乙二醇单油酸酯(增塑剂)的浓度增加,膨润率增加,耐水性(颜色)也为半透明~白浊而显示降低倾向。
就外观(气泡、透明性)、柔软性、伸缩性、强度及耐水性优良而言,使用水性聚合物乳剂6时,聚乙二醇单油酸酯的添加量为0.5~2.5质量%的范围内,使用水性聚合物乳剂9时,聚乙二醇单油酸酯的添加量为1.0~2.5质量%的范围,该范围的膨润率为30%以下。
[试验例4]添加物:增塑剂的探讨2
试验例2中,由于作为酯类非离子性表面活性剂的聚乙二醇单油酸酯的结果良好,故针对数种聚乙二醇单脂肪酸酯类表面活性剂也与试验例2同样地进行膜制备,针对所制备的膜进行与试验例2相同的评价(n=3)。其结果示于表7与表8。
[表7]
[表8]
如表7及表8所示,所探讨的全部的聚乙二醇单脂肪酸酯中,所得到的膜的柔软性及伸缩性改善,将该膜浸渍于纯水时的膨润率为30%以下,耐水性也优良。
[试验例5]添加物:油分的探讨1
于所述水性聚合物乳剂6中添加聚乙二醇单月桂酸酯(MYL-10V)与一定的水不溶性油分(添加量:1.25质量%及2.50质量%),与试验例2同样地进行膜制备,针对所制备的膜进行与试验例2相同的评价(n=3)。此外,其结果示于表9及表10。
[表9]
[表10]
如表9及表10所示,可知于聚乙二醇单月桂酸酯1.25质量%及2.50质量%配合下,配合了如肉豆蔻酸异丙酯、肉豆蔻酸辛基十二烷酯、生育酚乙酸酯、三(辛酸/癸酸)甘油酯、癸二酸二乙酯的酯类;如油酸的脂肪酸;如聚二甲基硅氧烷的聚硅氧烷;如荷荷巴油的植物油;如液体石蜡、角鲨烷的烃类的情况,也形成柔软性、伸缩性、强度及耐水性优良的皮膜。
[试验例6]添加物:油分的探讨2
于所述水性聚合物乳剂9中,添加聚乙二醇单油酸酯(MYO-10V)与一定的水不溶性油分(添加量:1.00质量%、涂布量:0.5g),与试验例2同样地进行膜制备,针对所制备的膜进行与试验例2相同的评价(n=3)。此外,其结果示于表11及表12。
[表11]
*:使用该油分者外观干净
[表12]
如表11及表12所示,可知于聚乙二醇单油酸酯1.00质量%配合下,配合了如肉豆蔻酸异丙酯、肉豆蔻酸辛基十二烷酯、生育酚乙酸酯、三(辛酸/癸酸)甘油酯、癸二酸二乙酯的酯类;如油酸的脂肪酸;如聚二甲基硅氧烷的聚硅氧烷;如荷荷巴油的植物油;如液体石蜡、角鲨烷的烃类的情况,也形成柔软性、伸缩性、强度及耐水性优良的皮膜。
由以上结果明显可知,本发明基剂由于配合有水不溶性的油分,故即使配合疏水性药物,也可抑制其凝集或沈淀。特别是作为该油分的酯类,一般而言也发挥皮肤吸收促进效果,因此药物的吸收促进效果受到期待。
工业实用性
本发明基剂,例如有用于作为杂货等非医药用外用剂及液体绊创膏等医药用外用剂的基剂。该非医药用外用剂有用于日常生活领域,医药用外用剂有用于医药品领域。
Claims (14)
1.一种非水膨润性的皮膜形成型外用剂基剂,其包含如下成分A~成分C:
A)皮膜形成剂,其由选自(甲基)丙烯酸类聚合物及分子内包含(甲基)丙烯酸类单体的共聚物的聚合物粒子分散于水介质中而成的水性聚合物乳剂所构成,其中所述聚合物的玻璃化转变温度及所述乳剂的最低成膜温度均为30℃以下,且将所形成的皮膜浸渍于水中24小时使其膨润时的由下述式所算出的膨润率小于30%,
膨润率(%)=(W1-W2)/W1×100
式中,W1表示浸渍前重量(g)、W2表示浸渍后重量(g);
B)增塑剂,其为选自酯类非离子性表面活性剂及纤维素类中的1种以上;及
C)载体溶剂,其为水、或水及基剂总量中小于20质量%的有机溶剂。
2.根据权利要求1所述的皮膜形成型外用剂基剂,其进一步包含水不溶性的油分。
3.根据权利要求1所述的皮膜形成型外用剂基剂,其中,
所述聚合物为(甲基)丙烯酸烷基酯聚合物、或包含(甲基)丙烯酸烷基酯单体的共聚物。
4.根据权利要求1所述的皮膜形成型外用剂基剂,其中,
所述聚合物粒子的平均粒径为10~300nm的范围内。
5.根据权利要求1所述的皮膜形成型外用剂基剂,其中,
所述水性乳剂中的聚合物固体成分量为20~70质量%的范围内。
6.根据权利要求1所述的皮膜形成型外用剂基剂,其中,
所述酯类非离子性表面活性剂为聚乙二醇单脂肪酸酯,
所述纤维素类为羟丙基纤维素。
7.根据权利要求1所述的非水膨润性的皮膜形成型外用剂基剂,其中,
所述水不溶性的油分为选自酯类、烃类、脂肪酸、动植物油及聚硅氧烷中的1种以上。
8.根据权利要求7所述的皮膜形成型外用剂基剂,其中,
酯类为肉豆蔻酸异丙酯、肉豆蔻酸辛基十二烷酯、生育酚乙酸酯、三(辛酸/癸酸)甘油酯、或癸二酸二乙酯;
烃类为液体石蜡、角鲨烷、或凡士林;
脂肪酸为月桂酸、肉豆蔻酸、硬脂酸、异硬脂酸、或油酸;
动植物油为蓖麻油、荷荷巴油、或澳洲坚果油;或
聚硅氧烷为聚二甲基硅氧烷。
9.一种非医药用外用剂,其包含权利要求1~8中任一项所述的皮膜形成型外用剂基剂。
10.一种医药用外用剂,其包含权利要求1~8中任一项所述的皮膜形成型外用剂基剂与药效成分。
11.根据权利要求10所述的医药用外用剂,其为液体绊创膏。
12.根据权利要求10所述的医药用外用剂,其中,
所述药效成分为杀菌消毒剂、足癣药、止痒剂、保湿剂、或镇痛消炎剂。
13.根据权利要求9所述的非医药用外用剂,其中,
外用剂被封入于推针型容器、滚珠容器或迷你滚珠容器、喷雾容器、或附刷毛容器。
14.根据权利要求10所述的医药用外用剂,其中,
外用剂被封入于推针型容器、滚珠容器或迷你滚珠容器、喷雾容器、或附刷毛容器。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2022/015988 WO2023188108A1 (ja) | 2022-03-30 | 2022-03-30 | 水非膨潤性の皮膜形成型外用剤基剤 |
JPPCT/JP2022/015988 | 2022-03-30 | ||
PCT/JP2022/032519 WO2023188456A1 (ja) | 2022-03-30 | 2022-08-30 | 水非膨潤性の皮膜形成型外用剤基剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117597148A true CN117597148A (zh) | 2024-02-23 |
Family
ID=88021832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202280046831.5A Pending CN117597148A (zh) | 2022-03-30 | 2022-08-30 | 非水膨润性的皮膜形成型外用剂基剂 |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP7349048B1 (zh) |
KR (1) | KR20240010029A (zh) |
CN (1) | CN117597148A (zh) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59139325A (ja) | 1982-10-19 | 1984-08-10 | Nissan Chem Ind Ltd | 透明速乾性塗布剤組成物 |
JPH03275619A (ja) | 1990-03-23 | 1991-12-06 | Nitsusui Seiyaku Kk | 外用剤組成物 |
JP3117502B2 (ja) | 1991-08-27 | 2000-12-18 | 株式会社資生堂 | 皮膚外用剤 |
JP3414423B2 (ja) | 1992-11-27 | 2003-06-09 | 積水化学工業株式会社 | 眠気防止用外用剤及び貼付剤 |
JPH092943A (ja) | 1995-06-21 | 1997-01-07 | Lion Corp | 被膜形成型外用液剤 |
JP5413900B2 (ja) * | 2009-12-16 | 2014-02-12 | クラシエホームプロダクツ株式会社 | 手指用外用剤 |
JP2015199702A (ja) | 2014-03-31 | 2015-11-12 | 株式会社コーセー | 人工爪被覆用組成物 |
JP2018095559A (ja) * | 2016-12-08 | 2018-06-21 | ケン・プロダクツ株式会社 | メイクアップ化粧料及びメイクアップ方法 |
JP2021006522A (ja) * | 2019-06-27 | 2021-01-21 | ロート製薬株式会社 | 被膜形成性皮膚外用組成物 |
-
2022
- 2022-08-30 JP JP2022578648A patent/JP7349048B1/ja active Active
- 2022-08-30 KR KR1020237043825A patent/KR20240010029A/ko active Search and Examination
- 2022-08-30 CN CN202280046831.5A patent/CN117597148A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
JPWO2023188456A1 (zh) | 2023-10-05 |
KR20240010029A (ko) | 2024-01-23 |
JP7349048B1 (ja) | 2023-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2611412B2 (en) | Crosslinked acrylic copolymers | |
BR112012007486B1 (pt) | Co-polímero anfifílico super-hidrofílico e processo para fazer um co-polímero anfifílico super-hidrofílico | |
WO2005044216A1 (ja) | 皮膚外用剤 | |
CN107206095A (zh) | 含有脂质肽型化合物的经皮吸收基材 | |
JP7374755B2 (ja) | 皮膚外用組成物 | |
TW200536562A (en) | Water-soluble thickener and cosmetic preparation containing same | |
WO2016121822A1 (ja) | 脂質ペプチド型化合物を含有する保湿基材 | |
JP2002284621A (ja) | 皮膚及び頭髪に潤いを与える化粧用不粘着性モイスチャライザー | |
TW200817040A (en) | Emulsion composition with good feeling of use | |
WO2023188456A1 (ja) | 水非膨潤性の皮膜形成型外用剤基剤 | |
JP6260111B2 (ja) | 抗しわ組成物及び化粧料 | |
BR102018006449A2 (pt) | composições tópicas compreendendo retinoides e agentes de limpeza poliméricos de baixa irritação | |
CN107708660A (zh) | 包含脂质肽型化合物的棒状基材 | |
CN117597148A (zh) | 非水膨润性的皮膜形成型外用剂基剂 | |
JP7349047B1 (ja) | 水膨潤性の皮膜形成型外用剤基剤 | |
JP4136963B2 (ja) | 毛髪化粧料 | |
WO2023188457A1 (ja) | 水膨潤性の皮膜形成型外用剤基剤 | |
TW202408460A (zh) | 非水膨潤性之皮膜形成型外用劑基劑 | |
JP6815719B2 (ja) | 海島構造を有する被膜及びこれを形成する組成物 | |
JP7330557B2 (ja) | キシログルカン含有ゲル状組成物 | |
JP2002226354A (ja) | ピールオフ型パック化粧料 | |
JPH09249520A (ja) | ゲル状乳化組成物 | |
JP2009221183A (ja) | 毛髪化粧料 | |
JP3351954B2 (ja) | 乳化組成物 | |
WO2023119575A1 (ja) | 化粧料用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40105637 Country of ref document: HK |